# Virtus Investment Partners, Inc.: financial statements, quarterly

VRTS · NYSE · CIK 883237 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrts.md) · [Financials](/companies/vrts/financials.md) · [Filings](/companies/vrts/filings.md) · [Insiders](/companies/vrts/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vrts/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [219](/filings/0000883237-24-000122.md) | [215 d](/filings/0000883237-26-000009.md) | [222](/filings/0000883237-25-000051.md) | [224](/filings/0000883237-25-000114.md) | [227](/filings/0000883237-25-000127.md) | [233 d](/filings/0000883237-26-000009.md) | [218](/filings/0000883237-26-000026.md) | [211](/filings/0000883237-26-000048.md) | [216](/filings/0000883237-25-000127.md) | [208 d](/filings/0000883237-26-000009.md) | [200](/filings/0000883237-26-000026.md) | [201](/filings/0000883237-26-000048.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [44.9](/filings/0000883237-24-000122.md) | [39.0 d](/filings/0000883237-26-000009.md) | [32.3](/filings/0000883237-25-000051.md) | [44.2](/filings/0000883237-25-000114.md) | [55.3](/filings/0000883237-25-000127.md) | [50.7 d](/filings/0000883237-26-000009.md) | [36.6](/filings/0000883237-26-000026.md) | [45.2](/filings/0000883237-26-000048.md) | [47.1](/filings/0000883237-25-000127.md) | [39.8 d](/filings/0000883237-26-000009.md) | [15.4](/filings/0000883237-26-000026.md) | [27.3](/filings/0000883237-26-000048.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [12.2](/filings/0000883237-24-000122.md) | [13.3 d](/filings/0000883237-26-000009.md) | [8.8](/filings/0000883237-25-000051.md) | [11.7](/filings/0000883237-25-000114.md) | [15.8](/filings/0000883237-25-000127.md) | [19.0 d](/filings/0000883237-26-000009.md) | [12.4](/filings/0000883237-26-000026.md) | [12.4](/filings/0000883237-26-000048.md) | [13.1](/filings/0000883237-25-000127.md) | [13.4 d](/filings/0000883237-26-000009.md) | [7.2](/filings/0000883237-26-000026.md) | [8.4](/filings/0000883237-26-000048.md) |
| Net income | $m | [38.2](/filings/0000883237-24-000122.md) | [38.5 d](/filings/0000883237-26-000009.md) | [37.9](/filings/0000883237-25-000051.md) | [26.0](/filings/0000883237-25-000114.md) | [49.1](/filings/0000883237-25-000127.md) | [39.5 d](/filings/0000883237-26-000009.md) | [28.1](/filings/0000883237-26-000026.md) | [42.7](/filings/0000883237-26-000048.md) | [31.3](/filings/0000883237-25-000127.md) | [33.9 d](/filings/0000883237-26-000009.md) | [6.2](/filings/0000883237-26-000026.md) | [44.6](/filings/0000883237-26-000048.md) |
| Diluted EPS | $ per share | [4.19](/filings/0000883237-24-000122.md) | not reported | [4.10](/filings/0000883237-25-000051.md) | [2.43](/filings/0000883237-25-000114.md) | [5.71](/filings/0000883237-25-000127.md) | not reported | [4.05](/filings/0000883237-26-000026.md) | [6.12](/filings/0000883237-26-000048.md) | [4.65](/filings/0000883237-25-000127.md) | not reported | [1.05](/filings/0000883237-26-000026.md) | [6.68](/filings/0000883237-26-000048.md) |
| Basic EPS | $ per share | [4.26](/filings/0000883237-24-000122.md) | not reported | [4.19](/filings/0000883237-25-000051.md) | [2.47](/filings/0000883237-25-000114.md) | [5.80](/filings/0000883237-25-000127.md) | not reported | [4.12](/filings/0000883237-26-000026.md) | [6.18](/filings/0000883237-26-000048.md) | [4.73](/filings/0000883237-25-000127.md) | not reported | [1.07](/filings/0000883237-26-000026.md) | [6.79](/filings/0000883237-26-000048.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,765](/filings/0000883237-23-000143.md) | [3,679](/filings/0000883237-25-000010.md) | [3,548](/filings/0000883237-24-000050.md) | [3,648](/filings/0000883237-24-000103.md) | [3,602](/filings/0000883237-24-000122.md) | [3,994](/filings/0000883237-26-000009.md) | [3,688](/filings/0000883237-25-000051.md) | [3,696](/filings/0000883237-25-000114.md) | [3,906](/filings/0000883237-25-000127.md) | [4,291](/filings/0000883237-26-000048.md) | [4,562](/filings/0000883237-26-000026.md) | [4,536](/filings/0000883237-26-000048.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [2,801](/filings/0000883237-23-000143.md) | [2,705](/filings/0000883237-25-000010.md) | [2,557](/filings/0000883237-24-000050.md) | [2,646](/filings/0000883237-24-000103.md) | [2,611](/filings/0000883237-24-000122.md) | [2,986](/filings/0000883237-26-000009.md) | [2,671](/filings/0000883237-25-000051.md) | [2,675](/filings/0000883237-25-000114.md) | [2,883](/filings/0000883237-25-000127.md) | [3,253](/filings/0000883237-26-000048.md) | [3,451](/filings/0000883237-26-000026.md) | [3,385](/filings/0000883237-26-000048.md) |
| Long-term debt | $m | [274](/filings/0000883237-23-000143.md) | [253](/filings/0000883237-25-000010.md) | [253](/filings/0000883237-24-000050.md) | [248](/filings/0000883237-24-000103.md) | [237](/filings/0000883237-24-000122.md) | [232](/filings/0000883237-26-000009.md) | [232](/filings/0000883237-25-000051.md) | [231](/filings/0000883237-25-000114.md) | [391](/filings/0000883237-25-000127.md) | [390](/filings/0000883237-26-000048.md) | [439](/filings/0000883237-26-000026.md) | [419](/filings/0000883237-26-000048.md) |
| Shareholders' equity | $m | [862](/filings/0000883237-23-000143.md) | [864](/filings/0000883237-25-000010.md) | [872](/filings/0000883237-24-000050.md) | [869](/filings/0000883237-24-000103.md) | [889](/filings/0000883237-24-000122.md) | [897](/filings/0000883237-26-000009.md) | [894](/filings/0000883237-25-000051.md) | [896](/filings/0000883237-25-000114.md) | [919](/filings/0000883237-25-000127.md) | [934](/filings/0000883237-26-000048.md) | [917](/filings/0000883237-26-000026.md) | [945](/filings/0000883237-26-000048.md) |

- Cash and equivalents: not reported
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [128 d](/filings/0000883237-24-000122.md) | [7.3 d](/filings/0000883237-26-000009.md) | [(34.5)](/filings/0000883237-25-000051.md) | [70.0 d](/filings/0000883237-25-000114.md) | [69.1 d](/filings/0000883237-25-000127.md) | [(103) d](/filings/0000883237-26-000009.md) | [(3.8)](/filings/0000883237-26-000026.md) | [75.8 d](/filings/0000883237-26-000048.md) | [108 d](/filings/0000883237-25-000127.md) | [(247) d](/filings/0000883237-26-000009.md) | [35.9](/filings/0000883237-26-000026.md) | [57.4 d](/filings/0000883237-26-000048.md) |
| Capital expenditure | $m | [3.9 d](/filings/0000883237-24-000122.md) | [2.4 d](/filings/0000883237-26-000009.md) | [1.9](/filings/0000883237-25-000051.md) | [1.3 d](/filings/0000883237-25-000114.md) | [0.4 d](/filings/0000883237-25-000127.md) | [1.9 d](/filings/0000883237-26-000009.md) | [3.0](/filings/0000883237-26-000026.md) | [1.6 d](/filings/0000883237-26-000048.md) | [1.4 d](/filings/0000883237-25-000127.md) | [0.9 d](/filings/0000883237-26-000009.md) | [2.4](/filings/0000883237-26-000026.md) | [1.3 d](/filings/0000883237-26-000048.md) |
| Dividends paid | $m | [12.0 d](/filings/0000883237-24-000122.md) | [13.7 d](/filings/0000883237-26-000009.md) | [14.9](/filings/0000883237-25-000051.md) | [13.7 d](/filings/0000883237-25-000114.md) | [13.7 d](/filings/0000883237-25-000127.md) | [15.9 d](/filings/0000883237-26-000009.md) | [17.1](/filings/0000883237-26-000026.md) | [15.8 d](/filings/0000883237-26-000048.md) | [15.4 d](/filings/0000883237-25-000127.md) | [16.3 d](/filings/0000883237-26-000009.md) | [17.9](/filings/0000883237-26-000026.md) | [16.3 d](/filings/0000883237-26-000048.md) |
| Share repurchases | $m | [15.0 d](/filings/0000883237-24-000122.md) | [20.0 d](/filings/0000883237-26-000009.md) | [5.0](/filings/0000883237-25-000051.md) | [12.5 d](/filings/0000883237-25-000114.md) | [14.9 d](/filings/0000883237-25-000127.md) | [12.5 d](/filings/0000883237-26-000009.md) | [20.0](/filings/0000883237-26-000026.md) | [30.0 d](/filings/0000883237-26-000048.md) | [0.0 d](/filings/0000883237-25-000127.md) | [10.0 d](/filings/0000883237-26-000009.md) | [10.0](/filings/0000883237-26-000026.md) | [10.5 d](/filings/0000883237-26-000048.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,463](/filings/0000883237-23-000143.md) | [7,410](/filings/0000883237-24-000050.md) | [7,385](/filings/0000883237-24-000103.md) | [7,379](/filings/0000883237-24-000122.md) | [7,287](/filings/0000883237-25-000051.md) | [7,242](/filings/0000883237-25-000114.md) | [7,176](/filings/0000883237-25-000127.md) | [7,073](/filings/0000883237-26-000026.md) | [6,922](/filings/0000883237-26-000048.md) | [6,867](/filings/0000883237-25-000127.md) | [6,806](/filings/0000883237-26-000026.md) | [6,778](/filings/0000883237-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,622,690 at 2026-07-30, from the cover of the [10-Q filed 2026-08-07](/filings/0000883237-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.